These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1866076)

  • 1. Biocompatibility of PMMA membranes used in haemofiltration and haemodiafiltration: beta 2-microglobulin removal and release of granulocyte elastase.
    Hillion D; Haas T; Uzan M; Pertuiset N; Beyne P
    Nephrol Dial Transplant; 1991; 6 Suppl 2():84-5. PubMed ID: 1866076
    [No Abstract]   [Full Text] [Related]  

  • 2. The rôle of adsorption in beta 2-microglobulin removal.
    David S; Canino F; Ferrari ME; Cambi V
    Nephrol Dial Transplant; 1991; 6 Suppl 2():64-8. PubMed ID: 1866072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodiafiltration versus paired filtration dialysis: evaluation of in vivo solute removal.
    Bufano G; Ariano R; Pecchini P; Pecchini F
    Nephrol Dial Transplant; 1991; 6 Suppl 2():82-3. PubMed ID: 1866075
    [No Abstract]   [Full Text] [Related]  

  • 4. Biocompatibility and capability of haemopurification systems: review and future development.
    Ota K
    Nephrol Dial Transplant; 1991; 6 Suppl 2():86-90. PubMed ID: 1866077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta 2-microglobulin kinetics during haemofiltration.
    Floege J; Wilks M; Shaldon S; Koch KM; Smeby LC
    Nephrol Dial Transplant; 1988; 3(6):784-9. PubMed ID: 3147420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of a new high-flux cellulose acetate membrane.
    Schaefer RM; Huber L; Gilge U; Bausewein K; Vienken J; Heidland A
    Int J Artif Organs; 1989 Feb; 12(2):85-90. PubMed ID: 2651325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-flux synthetic versus cellulosic membranes for beta 2-microglobulin removal during hemodialysis, hemodiafiltration and hemofiltration.
    Floege J; Granolleras C; Deschodt G; Heck M; Baudin G; Branger B; Tournier O; Reinhard B; Eisenbach GM; Smeby LC
    Nephrol Dial Transplant; 1989; 4(7):653-7. PubMed ID: 2510064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term multicentre study on beta 2-microglobulin removal by PMMA BK membrane.
    Arakawa M
    Nephrol Dial Transplant; 1991; 6 Suppl 2():69-74. PubMed ID: 1866073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of three haemodialysers containing PMMA membranes of different surface area, with special attention to thrombogenicity.
    Falkenhagen D; Brown GS
    Nephrol Dial Transplant; 1991; 6 Suppl 2():43-8. PubMed ID: 1830939
    [No Abstract]   [Full Text] [Related]  

  • 10. [Correlation of complement activation, cytokine liberation and beta 2 microglobulin in the use of various dialysis and hemofiltration membranes].
    Falkenhagen D; Thomaneck U; Brown GS; Werner H; Klinkmann H
    Z Urol Nephrol; 1989 Oct; 82(10):541-50. PubMed ID: 2692346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
    Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
    Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different complement and granulocyte activation in patients dialyzed with PMMA dialyzers.
    Hörl WH; Riegel W; Schollmeyer P; Rautenberg W; Neumann S
    Clin Nephrol; 1986 Jun; 25(6):304-7. PubMed ID: 3015463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta 2-Microglobulin and granulocyte elastase.
    Wehle B; Bergstrom J; Kishimoto T; Lantz B; Levin N; Klinkmann H
    Nephrol Dial Transplant; 1993; 8 Suppl 2():20-4. PubMed ID: 8272248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different elimination patterns of beta-trace protein, beta2-microglobulin and cystatin C in haemodialysis, haemodiafiltration and haemofiltration.
    Lindström V; Grubb A; Alquist Hegbrant M; Christensson A
    Scand J Clin Lab Invest; 2008; 68(8):685-91. PubMed ID: 18609120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biocompatibility of synthetic membrane for blood purification therapy].
    Akizawa T; Nabeshima K; Kawabe S
    Nihon Rinsho; 1991 Dec; 49 Suppl():53-60. PubMed ID: 1808312
    [No Abstract]   [Full Text] [Related]  

  • 16. beta 2-Microglobulin and other low molecular weight proteins in haemodiafiltrates and in haemofiltrates.
    Montali U; Pilone N; Cioni L; Ronca G
    Int J Tissue React; 1984; 6(1):71-4. PubMed ID: 6370888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediators of complement-independent granulocyte activation during haemodialysis: role of calcium, prostaglandins and leukotrienes.
    Böhler J; Donauer J; Birmelin M; Schollmeyer PJ; Hörl WH
    Nephrol Dial Transplant; 1993; 8(12):1359-65. PubMed ID: 8159305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical and parametric analysis of beta-2-microglobulin removal from uremic patients in high flux hemodialysis.
    Lee CJ; Hsiong CH; Chang YL; Cheng CH; Lian JD
    ASAIO J; 1994; 40(1):62-6. PubMed ID: 8186494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dialysis amyloidosis and beta-2-microglobulin].
    Sulková S; Votruba T
    Cas Lek Cesk; 1989 Jan; 128(3):68-73. PubMed ID: 2655913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of various treatment modes in terms of beta 2-microglobulin removal: hemodialysis, hemofiltration, and push/pull HDF.
    Shinzato T; Kobayakawa H; Maeda K
    Artif Organs; 1989 Feb; 13(1):66-70. PubMed ID: 2653287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.